| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/11/2014 | US20140255435 Vaccine |
| 09/11/2014 | US20140255429 Methods of Treating Autoimmune Diseases with DLL4 Antagonists |
| 09/11/2014 | US20140255427 Combination therapy with an anti - cd19 antibody and a nitrogen mustard |
| 09/11/2014 | US20140255426 Wnt pathway inhibitors for treating viral infections |
| 09/11/2014 | US20140255425 Multi-CBV Vaccine for Preventing or Treating Type I Diabetes |
| 09/11/2014 | US20140255420 Combination Therapy of Beta-Glycolipids and Antibodies for the Treatment of Immune-Related Disorders |
| 09/11/2014 | US20140255419 Method of Treating Stress Hyperglycemia with Human Antibodies to the Glucagon Receptor |
| 09/11/2014 | US20140255413 Combination therapy for neoplasia treatment |
| 09/11/2014 | US20140255411 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
| 09/11/2014 | US20140255410 Specific binding proteins and uses thereof |
| 09/11/2014 | US20140255408 Bispecific EGFR/C-Met Antibodies |
| 09/11/2014 | US20140255404 Pulmonary hypertension |
| 09/11/2014 | US20140255402 Method of treating leukemia in a mammal |
| 09/11/2014 | US20140255396 Multiple-variable dose regimen for treating tnfalpha-related disorders |
| 09/11/2014 | US20140255391 Methods for the treatment of il-1beta related diseases |
| 09/11/2014 | US20140255390 Method of Treating Rheumatoid Arthritis With An Anti-IL-6R Antibody |
| 09/11/2014 | US20140255389 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
| 09/11/2014 | US20140255343 Dna vaccine, method of inducing the immune response, method of immunisation, antibodies specifically recognising the h5 haemagglutinin of an influenza virus and use of the dna vaccine |
| 09/11/2014 | US20140255304 Tdp-43 specific binding molecules |
| 09/10/2014 | EP2774984A1 Monoclonal antibody against human non-small-cell lung carcinoma and use thereof |
| 09/10/2014 | EP2774621A2 Treatment of immune disease by mucosal delivery of antigens |
| 09/10/2014 | EP2774620A1 Method for modulating weight loss |
| 09/10/2014 | EP2773960A1 Diagnostic and treatment of an androgen-independent prostate cancer |
| 09/10/2014 | EP2773957A1 Use of an anti-alpha-synuclein antibody to diagnose an elevated level of -synuclein in the brain |
| 09/10/2014 | EP2773773A1 T-cell receptor clonotypes shared among ankylosing spondylitis patients |
| 09/10/2014 | EP2773760A1 Double-stranded RNA for immunostimulation |
| 09/10/2014 | EP2773674A1 Immunologic constructs and methods |
| 09/10/2014 | EP2773671A1 Stable heterodimeric antibody design with mutations in the fc domain |
| 09/10/2014 | EP2773665A1 Antibodies and methods of treating cancer |
| 09/10/2014 | EP2773661A1 Method for preparing antibodies having improved properties |
| 09/10/2014 | EP2773660A2 Chimeric human-camel antigens and their use |
| 09/10/2014 | EP2773427A2 Medical use |
| 09/10/2014 | EP2773374A2 Methods for reducing the frequency and severity of acute exacerbations of asthma |
| 09/10/2014 | EP2773373A1 Methods of blocking cancer stem cell growth |
| 09/10/2014 | EP2773372A2 Vaccines directed against human enteroviruses |
| 09/10/2014 | EP2773371A1 Effect of an attenuated bordetella strain against allergic disease |
| 09/10/2014 | EP2773370A2 Protective vaccine based on staphylococcus aureus sa2451 protein |
| 09/09/2014 | USRE45123 Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis |
| 09/09/2014 | US8829175 Nucleic acids encoding polyvalent protein complexes |
| 09/09/2014 | US8829165 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |
| 09/09/2014 | US8829163 Liquid formulations for long-acting erythropoietin conjugate |
| 09/09/2014 | US8829150 Methods for polymering haptens into immunogens |
| 09/09/2014 | US8829028 5-HT4 receptor antagonists for the treatment of heart failure |
| 09/09/2014 | US8828998 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors |
| 09/09/2014 | US8828982 Pyrimidine derivatives for the prevention of HIV infection |
| 09/09/2014 | US8828961 Methods and compositions to protect aquatic invertebrates from disease |
| 09/09/2014 | US8828957 Methods for generating immunity to antigen |
| 09/09/2014 | US8828950 Caspase inhibitors in the treatment of infection-associated preterm delivery |
| 09/09/2014 | US8828948 Method of treating a patient having an autoimmune disorder by administering BAFFR polypeptide |
| 09/09/2014 | US8828945 Inactivation of smooth muscle tissue |
| 09/09/2014 | US8828934 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 09/09/2014 | US8828932 Bifunctional molecules for inactivating HIV and blocking HIV entry |
| 09/09/2014 | US8828929 Cytotoxic T cell epitope peptide for SARS coronavirus, and use thereof |
| 09/09/2014 | US8828927 Elastin digest compositions and methods utilizing same |
| 09/09/2014 | US8828925 Etoposide and doxorubicin conjugates for drug delivery |
| 09/09/2014 | US8828924 Methods of treating a diabetic embryopathy |
| 09/09/2014 | US8828726 Circular nucleic acid vectors, and methods for making and using the same |
| 09/09/2014 | US8828723 Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC |
| 09/09/2014 | US8828717 Framework residue substituted humanized COL-1 antibodies and their use |
| 09/09/2014 | US8828687 Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions |
| 09/09/2014 | US8828670 Method for the production of proteins and peptides |
| 09/09/2014 | US8828669 Methods of screening for a compound that inhibits the interaction between BAFF and BCMA |
| 09/09/2014 | US8828668 Markers for determination of patient responsiveness |
| 09/09/2014 | US8828665 Compounds and methods for use in detecting gabapentin |
| 09/09/2014 | US8828422 Stabilized liquid egg material for extended shelf life |
| 09/09/2014 | US8828409 Vaccine comprising recombinant CLPP protein of Streptococcus pneumoniae |
| 09/09/2014 | US8828408 Compositions and methods for vaccinating against HSV-2 |
| 09/09/2014 | US8828407 Chimaeric protein |
| 09/09/2014 | US8828406 Influenza viruses and uses thereof |
| 09/09/2014 | US8828405 Method to enhance an immune response of nucleic acid vaccination |
| 09/09/2014 | US8828404 Vaccine and method for treatment of neurodegenerative diseases |
| 09/09/2014 | US8828403 Anti-tumor immunotherapy |
| 09/09/2014 | US8828402 Augmentation of titer for vaccination in animals |
| 09/09/2014 | US8828400 Antibody that binds to H-1 parvovirus |
| 09/09/2014 | US8828399 Cytomegalovirus surface protein complex for use in vaccines and as a drug target |
| 09/09/2014 | US8828398 Pharmaceutical composition for treating and/or preventing cancer |
| 09/09/2014 | US8828397 Anti-PSGL-1 antibodies and methods of inducing cell death of an activated T cell |
| 09/09/2014 | US8828396 Silent Fc variants of anti-CD40 antibodies |
| 09/09/2014 | US8828395 Antibodies that bind tyrosyl-tRNA synthetases |
| 09/09/2014 | US8828394 Methods for treating IgE-mediated disorder |
| 09/09/2014 | US8828393 Methods for the therapy of inflammatory bowel disease using a type-1 interferon antagonist |
| 09/09/2014 | US8828392 Histone deacetylase (HDAC) inhibitors (PXD101) for the treatment of cancer alone or in combination with chemotherapeutic agent |
| 09/09/2014 | US8828391 Method for EGFR directed combination treatment of non-small cell lung cancer |
| 09/09/2014 | US8828390 Uses of NOGO-A inhibitors and related methods |
| 09/09/2014 | US8828389 Methods of diagnosing ALS |
| 09/09/2014 | US8828388 Antibodies immunoreactive with heregulin-coupled HER3 |
| 09/09/2014 | US8828387 Antibody having anti-cancer activity |
| 09/09/2014 | US8828386 Method for extending pregnancy by reducing intraventricular hemorrhaging in patients exhibiting at least one symptom of preeclampsia and eclampsia |
| 09/09/2014 | US8828385 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 09/09/2014 | US8828384 Compounds |
| 09/09/2014 | US8828383 Nanocarriers with multi-photon response elements |
| 09/09/2014 | US8828382 Heparin-binding epidermal growth factor-like growth factor binding proteins |
| 09/09/2014 | US8828381 Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas |
| 09/09/2014 | US8828379 Disulphide bond-stabilized functional soluble MHC class II heterodimers |
| 09/09/2014 | CA2694805C Immunogenic epitopes of tumour-associated antigens |
| 09/09/2014 | CA2694735C Cell-penetrating peptides and use thereof bonded to biomolecules with therapeutic action |
| 09/09/2014 | CA2660324C Plasmids with immunological action |
| 09/09/2014 | CA2598879C Prostate stem cell |
| 09/09/2014 | CA2576798C Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use |
| 09/09/2014 | CA2530582C Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis |